Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii

被引:26
|
作者
Hanano, R
Reifenberg, K
Kaufmann, SHE [1 ]
机构
[1] Univ Ulm, Dept Immunol, D-89081 Ulm, Germany
[2] Univ Ulm, Cent Anim Facilities, D-89081 Ulm, Germany
[3] Max Planck Inst Infect Biol, Berlin, Germany
关键词
D O I
10.1128/IAI.66.1.305-314.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) T cells are pivotal for elimination of Pneumocystis carinii from infected lungs, and alveolar macrophages are considered the main effector cells clearing the infected host of P. carinii organisms. To investigate this issue, several mutant mouse strains were used in a previously established experimental setup which facilitates natural acquisition of disease through inhalation of airborne fungal organisms. Mutant mice deficient in major histocompatibility complex class II molecules (A beta(-/-)), T-cell receptor alpha beta cells (TCR beta(-/-)), or all mature T and B lymphocytes (RAG-1(-/-)) were naturally susceptible to P. carinii, whereas mouse mutants lacking the gamma interferon (IFN-gamma) receptor (IFN-gamma-R-/-) or tumor necrosis factor alpha (TNF-alpha) type I receptor (p55) (TNF-alpha-RI-/-) resisted disease acquisition. Analysis of pulmonary cytokine patterns and free radical expression revealed the presence of superoxide, nitric oxide, and interleukin-1 (IL-1) mRNA and elevated levels of IFN-gamma, TNF-alpha, and IL-12 in diseased TCR beta(-/-) and RAG-1(-/-) mice. Pulmonary macrophages of all diseased mouse mutants expressed scavenger and mannose receptors. Morbid A beta(-/-) mutants displayed significant NO levels and IL-1 mRNA only, whereas heterozygous controls did not exhibit any signs of disease. Interestingly, neither IFN-gamma nor TNF-alpha appeared to be essential for resisting natural infection with P. carinii, nor were these cytokines sufficient for mediating resistance during established disease in the absence of CD4(+) T lymphocytes. Taken together, the results indicated that an activated phagocyte system, as evidenced by cytokine and NO secretion, in diseased mutants was apparently operative but did not suffice for parasite clearance in the absence of CD4(+) TCR alpha beta cells. Therefore, additional pathways, possibly involving interactions of inflammatory cytokines with CD4(+) T lymphocytes, must contribute to successful resistance against P. carinii.
引用
收藏
页码:305 / 314
页数:10
相关论文
共 50 条
  • [31] Algorithmic analysis of in vitro chemotherapy against Pneumocystis carinii
    Atzori, C
    Agostoni, F
    Angeli, E
    Cargnel, A
    Drago, L
    Gismondo, MR
    JOURNAL OF EUKARYOTIC MICROBIOLOGY, 1997, 44 (06) : 30S - 30S
  • [32] PNEUMOCYSTIS-CARINII CHOROIDITIS IN A MALE-HOMOSEXUAL WITH AIDS AND DISSEMINATED PULMONARY AND EXTRAPULMONARY PNEUMOCYSTIS-CARINII INFECTION
    MACHER, AM
    BARDENSTEIN, DS
    ZIMMERMAN, LE
    STEIGMAN, CK
    PASTORE, L
    PORETZ, DM
    ERON, LJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (17): : 1092 - 1092
  • [33] Iron chelator daphnetin against Pneumocystis carinii in vitro
    叶彬
    郑玉强
    武卫华
    张静
    中华医学杂志(英文版), 2004, (11) : 104 - 108
  • [34] Iron chelator daphnetin against Pneumocystis carinii in vitro
    Ye, B
    Zheng, YQ
    Wu, WH
    Zhang, J
    CHINESE MEDICAL JOURNAL, 2004, 117 (11) : 1704 - 1708
  • [35] MONOCLONAL-ANTIBODIES AGAINST PNEUMOCYSTIS-CARINII
    CARTER, C
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1986, 80 (02) : 334 - 334
  • [36] IMPORTANCE OF ENDOGENOUS INTERLEUKIN-1 IN HOST-RESISTANCE AGAINST PNEUMOCYSTIS-CARINII
    CHEN, WX
    HAVELL, EA
    MOLDAWER, LL
    MCINTYRE, KW
    CHIZZONITE, RA
    HARMSEN, AG
    FASEB JOURNAL, 1992, 6 (05): : A1689 - A1689
  • [37] Sulfa resistance in mouse-derived Pneumocystis carinii
    Lane, B
    Hossler, P
    Bartlett, M
    Queener, S
    OReilly, T
    Smith, J
    Meshnick, S
    JOURNAL OF EUKARYOTIC MICROBIOLOGY, 1996, 43 (05) : S39 - S39
  • [38] Insufficient environment for lymphocyte migration into the lungs of neonatal mice in response to Pneumocystis carinii.
    Garvy, B
    Qureshi, M
    FASEB JOURNAL, 2000, 14 (06): : A1028 - A1028
  • [39] The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung
    Limper, AH
    Hoyte, JS
    Standing, JE
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09): : 2110 - 2117
  • [40] COMPARATIVE INTERACTIONS OF PNEUMOCYSTIS-CARINII AND ZYMOSAN WITH ALVEOLAR MACROPHAGES INVITRO
    HELMKE, RJ
    RICHEY, SA
    HIDALGO, HA
    FASEB JOURNAL, 1993, 7 (03): : A501 - A501